Jump to navigation Jump to search
This article needs to be updated.August 2018)(
This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. (December 2010) (Learn how and when to remove this template message)
Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety of their products, such as Spiriva (tiotropium bromide) and Combivent (ipratropium bromde/albuterol).
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|